Literature DB >> 29330970

Gamma-glutamyl transferase activity as a predictive marker for severity of obstructive sleep apnea syndrome and concomitant hypertension.

Fulsen Bozkus1, Nursel Dikmen2, Lutfu Saltuk Demir3.   

Abstract

BACKGROUND: Chronic intermittent hypia, inflammation and oxidative stress are involved in resultant obstructive sleep apnea syndrome (OSAS), which may affect numerous regulatory mechanisms that play a role in the regulation of blood pressure. Gamma-glutamyl transferase (GGT) is a novel marker in the prediction of cardiovascular risk.
OBJECTIVE: The objective of this study was to investigate the correlation of serum levels of GGT with hypertension and the degree of the upper airway obstruction in subjects with OSAS.
METHODS: A total of 270 subjects that met the inclusion criteria were enrolled in the study. The subjects were divided into four separate groups according to the apnea-hypopnea index (AHI) scores as the control group (AHI < 5), mild OSAS group (AHI 5-15), moderate OSAS group (AHI 16-30) and severe OSAS group (AHI >30). A further classification of the OSAS subjects was made in two groups based on the presence of hypertension.
RESULTS: The study included 43 control individuals and 59 subjects with mild, 54 subjects with moderate and 114 subjects with severe OSAS. The serum levels of GGT were found to be significantly correlated with OSAS severity (control group: 18 ± 3.3, mild OSAS: 23.6 ± 7.3, moderate OSAS: 26.4 ± 7.5 and severe OSAS: 39.8 ± 12). Serum levels of GGT were found to be significantly higher in OSAS subjects with concomitant hypertension than in the group without associated hypertension (P < .05). The results showed that the adjusted mean GGT under OSA without hypertension (Madj  = 28.76, SE = 0.71) was significantly lower than in cases with OSA with hypertension (Madj  = 42.79, SE = 1.19).
CONCLUSION: The present study indicated a strong correlation between high serum levels of GGT and concomitant hypertension in subjects with obstructive sleep apnea. This biomarker may be helpful in grading the severity of obstructive sleep apnea and correlated with hypertension in this population.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  gamma-glutamyl transferase; hypertension; obstructive sleep apnea

Mesh:

Substances:

Year:  2018        PMID: 29330970     DOI: 10.1111/crj.12765

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  3 in total

1.  Associations between cardiometabolic phenotypes and levels of TNF-α, CRP, and interleukins in obstructive sleep apnea.

Authors:  Quanming Fei; Yun Tan; Minhan Yi; Wangcheng Zhao; Yuan Zhang
Journal:  Sleep Breath       Date:  2022-08-19       Impact factor: 2.655

Review 2.  Evaluation of Blood Levels of C-Reactive Protein Marker in Obstructive Sleep Apnea: A Systematic Review, Meta-Analysis and Meta-Regression.

Authors:  Mohammad Moslem Imani; Masoud Sadeghi; Farid Farokhzadeh; Habibolah Khazaie; Serge Brand; Kenneth M Dürsteler; Annette Brühl; Dena Sadeghi-Bahmani
Journal:  Life (Basel)       Date:  2021-04-19

3.  The relation of dietary components with severity of obstructive sleep apnea in Cypriot patients: A randomized, stratified epidemiological study.

Authors:  Stavri Chrysostomou; Frangiskos Frangopoulos; Yiannis Koutras; Kosmia Andreou; Lydia Socratous; Konstantinos Giannakou
Journal:  PLoS One       Date:  2022-03-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.